About: Chapter 59 Respiratory Virus Vaccines

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Chapter 59 Respiratory Virus Vaccines Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Chapter 59 Respiratory Virus Vaccines
Creator	Boonnak, Kobporn Subbarao, Kanta Broadbent, Andrew
Source	Elsevier; PMC
abstract	Abstract This chapter reviews the main viral pathogens of the respiratory tract, the immune responses they induce, currently available vaccines, and vaccines that are in development to control them. The main viruses responsible for acute respiratory infection in people include respiratory syncytial, influenza, human parainfluenza, human metapneumo-, human rhino-, corona-, and adenoviruses. Licensed vaccines are available only for influenza virus, with vaccines against the other pathogens either in clinical trials or in preclinical stages of development. The majority of studies evaluating respiratory virus vaccines measure serum antibody responses, because, although both cellular and humoral responses contribute to the clearance of a primary infection, neutralizing antibodies are known to protect against secondary infection. Humoral responses can be readily detected after vaccination with inactivated or subunit vaccines; however, fewer individuals seroconvert after vaccination with live vaccines. Alternative immune mechanisms such as mucosal antibody responses are probably responsible for protection by live attenuated vaccines, and immune correlates of protection are under investigation.
has issue date	2015-12-31(xsd:dateTime)
bibo:doi	10.1016/b978-0-12-415847-4.00059-8
has license	els-covid
sha1sum (hex)	f25b4e8858297fd2716bfbf5c5c5d4dc95e9fec1
schema:url	https://doi.org/10.1016/b978-0-12-415847-4.00059-8
resource representing a document's title	Chapter 59 Respiratory Virus Vaccines
has PubMed Central identifier	PMC7149605
schema:publication	Mucosal Immunology
resource representing a document's body	covid:f25b4e8858297fd2716bfbf5c5c5d4dc95e9fec1#body_text
is schema:about of	named entity 'RESPIRATORY VIRUS' named entity 'VACCINES' named entity 'H1N1' named entity 'DCs' named entity 'IL-1' named entity 'genome' named entity 'immunostimulatory' named entity 'febrile' named entity 'CD40' named entity 'caspase-1' named entity 'vaccine' named entity 'vaccine' named entity 'adenovirus' named entity 'gene' named entity 'URT' named entity 'RSV' named entity 'adaptive immune responses' named entity 'pathogenesis' named entity 'luminal' named entity 'vaccine' named entity 'neutralizing antibodies' named entity 'CD4 +' named entity 'infection' named entity 'serum' named entity 'LRTI' named entity 'URT' named entity 'pattern recognition receptors' named entity 'TLR' named entity 'LRT' named entity 'IgA' named entity 'adenoviruses' named entity 'tonsils' named entity 'proinflammatory cytokines' named entity 'CD4' named entity 'immune response' named entity 'infection' named entity 'RSV' named entity 'Picornaviridae' named entity 'Intranasal administration' named entity 'Single-nucleotide polymorphisms' named entity 'influenza virus' named entity 'pregnant women' named entity 'Adenovirus' named entity 'respiratory illness' named entity 'LAIV' named entity 'vaccine' named entity 'lung' named entity 'antigens' named entity 'virus' named entity 'immune cells' named entity 'serum' named entity 'virus infection' named entity 'M2e' named entity 'DCs' named entity 'immune responses' named entity 'adjuvants' named entity 'parenteral' named entity 'RSV' named entity 'immunocompromised' named entity 'alveolar macrophages' named entity 'mannose' named entity 'LAIV' named entity 'Cellular immune responses' named entity 'RSV' named entity 'IP-10' named entity 'virus' named entity 'viruses' named entity 'respiratory tract infections' named entity 'influenza vaccine' named entity 'TGF-β' named entity 'mAbs' named entity 'influenza' named entity 'influenza' named entity 'necrosis' named entity 'homologous' named entity 'public health' named entity 'Syrian hamsters' named entity 'influenza' named entity 'adjuvanted' named entity 'alum' named entity 'germinal centers'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software